Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
2022 · EBioMedicine · 38 citations
https://doi.org/10.1016/j.ebiom.2022.104073